Details for Patent: 8,871,241
✉ Email this page to a colleague
Which drugs does patent 8,871,241 protect, and when does it expire?
Patent 8,871,241 protects ILUVIEN and YUTIQ and is included in two NDAs.
This patent has one hundred and seventy-six patent family members in twenty-seven countries.
Summary for Patent: 8,871,241
| Title: | Injectable sustained release delivery devices |
| Abstract: | An injectable drug delivery device includes a core containing one or more drugs and one or more polymers. The core may be surrounded by one or more polymer outer layers (referred to herein as "coatings," "skins," or "outer layers"). In certain embodiments, the device is formed by extruding or otherwise preforming a polymeric skin for a drug core. The drug core may be co-extruded with the skin, or inserted into the skin after the skin has been extruded, and possibly cured. In other embodiments, the drug core may be coated with one or more polymer coatings. These techniques may be usefully applied to fabricate devices having a wide array of drug formulations and skins that can be selected to control the release rate profile and various other properties of the drugs in the drug core in a form suitable for injection using standard or non-standard gauge needles. The device may be formed by combining at least one polymer, at least one drug, and at least one liquid solvent to form a liquid suspension or solution wherein, upon injection, such suspension or solution under goes a phase change and forms a gel. The configuration may provide for controlled release of the drug(s) for an extended period. |
| Inventor(s): | Chou; Kang-Jye (Watertown, MA), Guo; Hong (Belmont, MA), Ashton; Paul (Boston, MA), Shimizu; Robert W. (Acton, MA), Watson; David A. (Westwood, MA) |
| Assignee: | pSivida US, Inc. (Watertown, MA) |
| Application Number: | 10/714,549 |
|
Patent Claim Types: see list of patent claims | Delivery; Device; Use; Formulation; |
Drugs Protected by US Patent 8,871,241
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alimera Sciences Inc | ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923-001 | Sep 26, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Alimera Sciences Inc | YUTIQ | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 210331-001 | Oct 12, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,871,241
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2233112 | ⤷ Sign Up | 122014000063 | Germany | ⤷ Sign Up |
| European Patent Office | 2233112 | ⤷ Sign Up | 132014902285293 | Italy | ⤷ Sign Up |
| Argentina | 028372 | ⤷ Sign Up | |||
| Argentina | 039880 | ⤷ Sign Up | |||
| Argentina | 042917 | ⤷ Sign Up | |||
| Argentina | 042920 | ⤷ Sign Up | |||
| Argentina | 043356 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
